<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>healthcare costs &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/healthcare-costs/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jan 2026 17:21:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>healthcare costs &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Tiny Babies, Huge Bills: NICU’s Crucial Role</title>
		<link>https://bioengineer.org/tiny-babies-huge-bills-nicus-crucial-role/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jan 2026 17:20:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Health System Sustainability]]></category>
		<category><![CDATA[healthcare costs]]></category>
		<category><![CDATA[healthcare economics]]></category>
		<category><![CDATA[medical ethics]]></category>
		<category><![CDATA[Medical Resource Allocation]]></category>
		<category><![CDATA[neonatal intensive care]]></category>
		<category><![CDATA[neonatal intensive care (NICU)]]></category>
		<category><![CDATA[NICU Cost-Effectiveness]]></category>
		<category><![CDATA[Premature Infant Care]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tiny-babies-huge-bills-nicus-crucial-role/</guid>

					<description><![CDATA[In the quiet hum of neonatal intensive care units (NICUs) around the globe, a profound and complex narrative unfolds daily—one that intertwines advances in medicine with economic realities, ethical considerations, and the very fabric of healthcare systems. The article “Tiny babies, big bills: the vital role of the NICU in sustaining lives and health systems,” [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">321192</post-id>	</item>
		<item>
		<title>Heart Failure Impact: Utilization and Costs in Sweden</title>
		<link>https://bioengineer.org/heart-failure-impact-utilization-and-costs-in-sweden/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jan 2026 20:57:23 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Based on the research focus and content]]></category>
		<category><![CDATA[examining patterns of service use (hospitalizations]]></category>
		<category><![CDATA[healthcare costs]]></category>
		<category><![CDATA[Healthcare utilization]]></category>
		<category><![CDATA[here are 5 suitable tags: **Heart Failure Phenotypes]]></category>
		<category><![CDATA[Observational study]]></category>
		<category><![CDATA[specifically the economic burden analyzed. * **Observational Study:**]]></category>
		<category><![CDATA[Sweden Healthcare** * **Heart Failure Phenotypes:** Core to the study's analysis of differing outcomes and costs. * **Healthcare Utilization:** A primary subject]]></category>
		<category><![CDATA[visits). * **Healthcare Costs:** The other main subject]]></category>
		<guid isPermaLink="false">https://bioengineer.org/heart-failure-impact-utilization-and-costs-in-sweden/</guid>

					<description><![CDATA[In a groundbreaking observational study conducted in southwestern Sweden, researchers have illuminated the intricate dynamics of healthcare utilization and costs following a heart failure diagnosis. The work of Davidge, Halling, and Agvall introduces significant findings that could reshape our understanding of post-diagnosis trajectories across different heart failure phenotypes. This pivotal research, set to be published [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316652</post-id>	</item>
		<item>
		<title>Polypharmacy’s Impact on Seniors’ Healthcare Costs</title>
		<link>https://bioengineer.org/polypharmacys-impact-on-seniors-healthcare-costs/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 17 Dec 2025 11:17:03 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[doğrudan içeriği yansıtıyor. 2. **Healthcare Costs**: Araştırmanın temel bulgusu (sağlık harcamalarındaki artış). 3. **Older Adults**: Çal]]></category>
		<category><![CDATA[Geriatric Care **Etiket seçimlerimin gerekçesi:** 1. **Polypharmacy**: Makalenin ana konusu]]></category>
		<category><![CDATA[healthcare costs]]></category>
		<category><![CDATA[Medication management]]></category>
		<category><![CDATA[older adults]]></category>
		<category><![CDATA[polypharmacy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/polypharmacys-impact-on-seniors-healthcare-costs/</guid>

					<description><![CDATA[In a groundbreaking study set to be published in 2025, researchers have delved into the intricate relationship between polypharmacy among older adults and the skyrocketing healthcare expenditures in the United States. This study, spearheaded by a team led by scholars Pan, S., Li, S., and Shi, Y., employs a rigorous propensity score-matching methodology, ensuring that [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">308788</post-id>	</item>
		<item>
		<title>Reevaluating Ineffective Practices in Pressure Injury Care</title>
		<link>https://bioengineer.org/reevaluating-ineffective-practices-in-pressure-injury-care/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 18 Oct 2025 17:53:05 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[evidence-based practices]]></category>
		<category><![CDATA[healthcare costs]]></category>
		<category><![CDATA[low-value clinical practices]]></category>
		<category><![CDATA[pressure injury management]]></category>
		<category><![CDATA[scoping review]]></category>
		<guid isPermaLink="false">https://bioengineer.org/reevaluating-ineffective-practices-in-pressure-injury-care/</guid>

					<description><![CDATA[In the realm of modern healthcare, the management of pressure injuries—primarily in patients with limited mobility—has garnered significant attention from researchers and clinicians alike. A recent study published in BMC Health Services Research introduces a scoping review, delving into the low-value clinical practices that often permeate pressure injury management. This comprehensive examination, led by Jiang [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">283330</post-id>	</item>
		<item>
		<title>Healthcare Costs of ADHD-Related Adverse Events</title>
		<link>https://bioengineer.org/healthcare-costs-of-adhd-related-adverse-events/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 11 Sep 2025 11:58:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ADHD adverse events]]></category>
		<category><![CDATA[claims-based study]]></category>
		<category><![CDATA[healthcare costs]]></category>
		<category><![CDATA[healthcare system burden]]></category>
		<category><![CDATA[pediatric patients]]></category>
		<guid isPermaLink="false">https://bioengineer.org/healthcare-costs-of-adhd-related-adverse-events/</guid>

					<description><![CDATA[In a groundbreaking study published in Advances in Therapy, researchers led by Schein et al. reveal the staggering healthcare costs associated with adverse events in pediatric patients diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). The study, leveraging extensive claims data, highlights a critical and often overlooked aspect of ADHD management — the economic burden that adverse events [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">268689</post-id>	</item>
	</channel>
</rss>
